Literature DB >> 25605764

Combinational deletion of three membrane protein-encoding genes highly attenuates yersinia pestis while retaining immunogenicity in a mouse model of pneumonic plague.

Bethany L Tiner1, Jian Sha2, Michelle L Kirtley1, Tatiana E Erova1, Vsevolod L Popov3, Wallace B Baze4, Christina J van Lier1, Duraisamy Ponnusamy1, Jourdan A Andersson1, Vladimir L Motin5, Sadhana Chauhan1, Ashok K Chopra6.   

Abstract

Previously, we showed that deletion of genes encoding Braun lipoprotein (Lpp) and MsbB attenuated Yersinia pestis CO92 in mouse and rat models of bubonic and pneumonic plague. While Lpp activates Toll-like receptor 2, the MsbB acyltransferase modifies lipopolysaccharide. Here, we deleted the ail gene (encoding the attachment-invasion locus) from wild-type (WT) strain CO92 or its lpp single and Δlpp ΔmsbB double mutants. While the Δail single mutant was minimally attenuated compared to the WT bacterium in a mouse model of pneumonic plague, the Δlpp Δail double mutant and the Δlpp ΔmsbB Δail triple mutant were increasingly attenuated, with the latter being unable to kill mice at a 50% lethal dose (LD50) equivalent to 6,800 LD50s of WT CO92. The mutant-infected animals developed balanced TH1- and TH2-based immune responses based on antibody isotyping. The triple mutant was cleared from mouse organs rapidly, with concurrent decreases in the production of various cytokines and histopathological lesions. When surviving animals infected with increasing doses of the triple mutant were subsequently challenged on day 24 with the bioluminescent WT CO92 strain (20 to 28 LD50s), 40 to 70% of the mice survived, with efficient clearing of the invading pathogen, as visualized in real time by in vivo imaging. The rapid clearance of the triple mutant, compared to that of WT CO92, from animals was related to the decreased adherence and invasion of human-derived HeLa and A549 alveolar epithelial cells and to its inability to survive intracellularly in these cells as well as in MH-S murine alveolar and primary human macrophages. An early burst of cytokine production in macrophages elicited by the triple mutant compared to WT CO92 and the mutant's sensitivity to the bactericidal effect of human serum would further augment bacterial clearance. Together, deletion of the ail gene from the Δlpp ΔmsbB double mutant severely attenuated Y. pestis CO92 to evoke pneumonic plague in a mouse model while retaining the required immunogenicity needed for subsequent protection against infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25605764      PMCID: PMC4363438          DOI: 10.1128/IAI.02778-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  79 in total

Review 1.  Septic shock: pathogenesis.

Authors:  M P Glauser; G Zanetti; J D Baumgartner; J Cohen
Journal:  Lancet       Date:  1991-09-21       Impact factor: 79.321

2.  Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression.

Authors:  R A Edwards; L H Keller; D M Schifferli
Journal:  Gene       Date:  1998-01-30       Impact factor: 3.688

3.  Expression of heterologous O-antigen in Yersinia pestis KIM does not affect virulence by the intravenous route.

Authors:  P C F Oyston; J L Prior; S Kiljunen; M Skurnik; J Hill; R W Titball
Journal:  J Med Microbiol       Date:  2003-04       Impact factor: 2.472

4.  Effect of deletion of the lpxM gene on virulence and vaccine potential of Yersinia pestis in mice.

Authors:  Andrey P Anisimov; Rima Z Shaikhutdinova; Lyudmila N Pan'kina; Valentina A Feodorova; Elena P Savostina; Ol'ga V Bystrova; Buko Lindner; Aleksandr N Mokrievich; Irina V Bakhteeva; Galina M Titareva; Svetlana V Dentovskaya; Nina A Kocharova; Sof'ya N Senchenkova; Otto Holst; Zurab L Devdariani; Yuriy A Popov; Gerald B Pier; Yuriy A Knirel
Journal:  J Med Microbiol       Date:  2007-04       Impact factor: 2.472

5.  Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines.

Authors:  Lauriane E Quenee; Nancy A Ciletti; Derek Elli; Timothy M Hermanas; Olaf Schneewind
Journal:  Vaccine       Date:  2011-07-16       Impact factor: 3.641

6.  Evaluation of protective potential of Yersinia pestis outer membrane protein antigens as possible candidates for a new-generation recombinant plague vaccine.

Authors:  Tatiana E Erova; Jason A Rosenzweig; Jian Sha; Giovanni Suarez; Johanna C Sierra; Michelle L Kirtley; Christina J van Lier; Maxim V Telepnev; Vladimir L Motin; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

7.  Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks.

Authors:  Jian Sha; Janice J Endsley; Michelle L Kirtley; Sheri M Foltz; Matthew B Huante; Tatiana E Erova; Elena V Kozlova; Vsevolod L Popov; Linsey A Yeager; Irina V Zudina; Vladimir L Motin; Johnny W Peterson; Kristin L DeBord; Ashok K Chopra
Journal:  J Clin Microbiol       Date:  2011-03-02       Impact factor: 5.948

8.  Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation.

Authors:  Roberto Rebeil; Robert K Ernst; Clayton O Jarrett; Kristin N Adams; Samuel I Miller; B Joseph Hinnebusch
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

9.  A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.

Authors:  Jian Sha; Jason A Rosenzweig; Michelle L Kirtley; Christina J van Lier; Eric C Fitts; Elena V Kozlova; Tatiana E Erova; Bethany L Tiner; Ashok K Chopra
Journal:  Microb Pathog       Date:  2012-10-09       Impact factor: 3.738

10.  Identification of chromosomal genes in Yersinia pestis that influence type III secretion and delivery of Yops into target cells.

Authors:  Andrew S Houppert; Elizabeth Kwiatkowski; Elizabeth M Glass; Kristin L DeBord; Peter M Merritt; Olaf Schneewind; Melanie M Marketon
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

View more
  14 in total

1.  A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.

Authors:  Jian Sha; Michelle L Kirtley; Curtis Klages; Tatiana E Erova; Maxim Telepnev; Duraisamy Ponnusamy; Eric C Fitts; Wallace B Baze; Satheesh K Sivasubramani; William S Lawrence; Igor Patrikeev; Jennifer E Peel; Jourdan A Andersson; Elena V Kozlova; Bethany L Tiner; Johnny W Peterson; David McWilliams; Snehal Patel; Eric Rothe; Vladimir L Motin; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2016-07-05

Review 2.  Plague Vaccines: Status and Future.

Authors:  Wei Sun
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 3.  Contributions of Yersinia pestis outer membrane protein Ail to plague pathogenesis.

Authors:  Anna M Kolodziejek; Carolyn J Hovde; Scott A Minnich
Journal:  Curr Opin Infect Dis       Date:  2022-06-01       Impact factor: 4.968

4.  Structural Insights into the Yersinia pestis Outer Membrane Protein Ail in Lipid Bilayers.

Authors:  Samit Kumar Dutta; Yong Yao; Francesca M Marassi
Journal:  J Phys Chem B       Date:  2017-08-04       Impact factor: 2.991

5.  Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.

Authors:  Bethany L Tiner; Jian Sha; Duraisamy Ponnusamy; Wallace B Baze; Eric C Fitts; Vsevolod L Popov; Christina J van Lier; Tatiana E Erova; Ashok K Chopra
Journal:  Clin Vaccine Immunol       Date:  2015-10-07

6.  Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics.

Authors:  Jourdan A Andersson; Jian Sha; Michelle L Kirtley; Emily Reyes; Eric C Fitts; Sara M Dann; Ashok K Chopra
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

7.  Protective Immunity Elicited by Oral Immunization of Mice with Salmonella enterica Serovar Typhimurium Braun Lipoprotein (Lpp) and Acetyltransferase (MsbB) Mutants.

Authors:  Tatiana E Erova; Michelle L Kirtley; Eric C Fitts; Duraisamy Ponnusamy; Wallace B Baze; Jourdan A Andersson; Yingzi Cong; Bethany L Tiner; Jian Sha; Ashok K Chopra
Journal:  Front Cell Infect Microbiol       Date:  2016-11-10       Impact factor: 5.293

8.  Two Isoforms of Yersinia pestis Plasminogen Activator Pla: Intraspecies Distribution, Intrinsic Disorder Propensity, and Contribution to Virulence.

Authors:  Svetlana V Dentovskaya; Mikhail E Platonov; Tat'yana E Svetoch; Pavel Kh Kopylov; Tat'yana I Kombarova; Sergey A Ivanov; Rima Z Shaikhutdinova; Lyubov' V Kolombet; Sadhana Chauhan; Vitaly G Ablamunits; Vladimir L Motin; Vladimir N Uversky; Andrey P Anisimov
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 9.  Plague vaccines: new developments in an ongoing search.

Authors:  Jason A Rosenzweig; Emily K Hendrix; Ashok K Chopra
Journal:  Appl Microbiol Biotechnol       Date:  2021-06-18       Impact factor: 4.813

10.  Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague.

Authors:  Bethany L Tiner; Jian Sha; Yingzi Cong; Michelle L Kirtley; Jourdan A Andersson; Ashok K Chopra
Journal:  NPJ Vaccines       Date:  2016-10-13       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.